Longcarcinoom: Literatuur en referenties
|
|
- Lenard Hall
- 6 years ago
- Views:
Transcription
1 Longcarcinoom: Literatuur en referenties 1. Niet-invasieve stadiëring longcarcinoom - American Thoracic Society (ATS), European Respiratory Society (ERS). Pretreatment evaluation of non-small cell lung cancer. Am J Respir Crit Care Med 1997; 156: Micke P, Faldum A, Metz T, et al. Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer - what limits limited disease? Lung Cancer 2002; 37: Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111: Pfister DG, Johnson DH, Azzoli CG, et al. American Society of Clinical Oncology treatment of unresectable non-small cell lung cancer guideline: update J Clin Oncol 2004; 22: Postmus PE, Rocmans P, Asamura H, et al. IASLC consensus report: pretreatment minimal staging for non-small cell lung cancer. Lung Cancer 2003; 42 Suppl 1:3S-6S. - Silvestri GA, Tanoue LT, Margolis ML, Barker J, Detterbeck F. The noninvasive staging of non-small cell lung cancer: The guidelines. Chest 2003; 123 Suppl 1:147S-156S. - Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med 2004; 350: Spiro SG, Porter JC. Lung cancer-where are we today? Current advances in staging and non-surgical treatment. Am J Respir Crit Care Med 2002; 166: Stahel RA, Ginsberg R, Havemann K, et al. Staging and prognostic factors in small cell lung cancer: a consensus. Lung Cancer 1989; 5: Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer: A review of the current evidence. Chest 2003; 123 Suppl 1:137S-146S. - Vansteenkiste JF, Stroobants SG, De Leyn PR, et al. Lymph node staging in non-small cell lung cancer with FDG-PET scan: A prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 1998; 16: Invasieve locoregionale stadiëring van longcarcinoom - Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997; 111: Toloza EM, Harpole L, Detterbeck F, McCrory DC. Invasive staging of non-small cell lung cancer: a review of the current evidence. Chest 2003; 123 Suppl 1:157S-166S. Hfdst
2 3. Preoperatieve functionele evaluatie - ATS/ERS statement: Pretreatment evaluation of NSCLC. Am J Respir Crit Care Med 97. Vol 156, p Medical evaluation of the patient with potentially respectable lung cancer. Lung cancer: Principles and practice, Chapter 31: p Guidelines on the selection of patients with lung cancer for surgery. Thorax 2001; 56: Guidelines for perioperative cardiovascular evaluation for noncardiac surgery: an abridged version of the report of the American College of Cardiology/American Heart Association task forse on practical guidelines. Eagle et al, Mayo Clin Proc 1997; 72: Behandeling van vroege stadia Niet Kleincellig Longcarcinoma (NKCLC) - Blum RH. Adjuvant chemotherapy for lung cancer - a new standard of care. N Engl J Med 2004; 350: Bradley JD, Wahab S, Lockett MA, Perez CA, Purdy JA. Elective nodal failures are uncommon in medically inoperable patients with stage I non-small cell lung carcinoma treated with limited radiotherapy fields. Int J Radiat Oncol Biol Phys 2003; 56: Gauden S, Ramsay J, Tripcony L. The curative treatment by radiotherapy alone of stage I non-small cell carcinoma of the lung. Chest 1995; 108: Smythe WR. Treatment of stage I non-small cell lung carcinoma. Chest 2003; 123 Suppl 1:181S-187S. - Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med 2004; 350: The International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer. N Engl J Med 2004; 350: Behandeling van potentieel resecabel stadium III NKCLC - Andre F, Grunenwald D, Pignon JP, et al. Survival of patients with resected N2 non-smallcell lung cancer: evidence for a subclassification and implications. J Clin Oncol 2000;18: Bueno R, Richards WG, Swanson SJ, et al. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. Ann Thorac Surg 2000; 70: De Leyn P. Schoonhooghe P, Deneffe G, et al. Surgery for non-small cell lung cancer with unsuspected metastasis to ipsilateral mediastinal or subcarinal nodes (N2 disease). Eur J Cardiothorac Surg 1996; 10: Depierre A, Milleron B, Moro-Sibilot D, et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I, II, and IIIA non-small-cell lung cancer. J. Clin Oncol 2001;20: Detterbeck FC. Diagnosis and treatment of lung cancer. An evidence-based guide for the practicing clinician. W.B. Saunders company ISBN Hfdst
3 - Fernando HC, Goldstraw P. The accuracy of clinical intrathoracic staging as assessed by postsurgical pathological stage. Cancer 1990; 65: Funatsu T, Matsubaru Y, Hatakenaka R, et al. The role of mediastinoscopic biopsy in preoperative assessment of lung cancer. J Thorac Cardiovasc Surg 2002; 104: Lorent N, De Leyn P, Lievens Y, et al. Long-term survival of surgically staged IIIA-N2 nonsmall cell lung cancer treated with surgical combined modality approach: analysis of a 7- year experience. Ann Oncol 2004; 15: Martini N, Yellin A, Ginsberg RJ, et al. Management of non-small-cell lung cancer with direct mediastinal involvement. Ann Thorac Surg 1994;58: Pearson FG, Delarue NC, Ilves R, et al. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. J Thorac Cardiovasc Surg 1982; 83: PORT meta-analysis Trialists Group. Postoperative Radiotherapy in non-small-cell lung cancer. Systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 1998; 352: Robinson L, Wagner H, Ruckdeschel JC. Treatment of stage IIIA non-small cell lung cancer. Chest 2003; 123:202S-220S. - Rosell R, Gomez-Codina J, Camps C, et al. Preresectional chemotherapy in stage IIIA non-small cell lung cancer: a 7-year assessment of a randomized controlled trial. Lung Cancer 1999;47: Roth JA, Atkinson EN, Fossella F, et al. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. Lung Cancer 1998;21: Rusch VW, Giroux DJ, Kraut MJ, et al. et al. Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: initial results of Southwest Oncology Group Trial 9416 (Intergroup trial 0160). J Thorac Cardiovasc Surg 2001; 121: Behandeling gevorderde stadia Niet Kleincellig Longcarcinoma (NKCLC) 7. Behandeling Limited Disease Kleincellig Longcarcinoma (KCLC) - Aupérin A, Arriagada R, Pignon J-P, et al. Prophylactic cranial irradiation for patients with small cell lung cancer in complete remission. N Engl J Med 1999; 341: Choi NC, Carey R. Importance of radiation dose in achieving improved loco-regional tumor control in limited stage small cell lung carcinoma: an update. Int J Radiat Oncol Biol Phys 1989; 17: Coolen L, Vanden Eeckhout A, Deneffe G, Demedts M, Vansteenkiste J. Surgical treatment of small cell lung cancer. Eur J Cardiothorac Surg 1995; 9: Chrystal K, Cheong K, Harper P. Chemotherapy of small cell lung cancer: state of the art. Curr Opin Oncol 2004; 16: De Ruysscher D, Vansteenkiste J. Chest radiotherapy in limited stage small cell lung cancer: Facts, questions, prospects. Radiother Oncol 2000; 55:1-9. Hfdst
4 - Gregor A, Drings P, Burghouts J, et al. Randomized trial of alternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer: a European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study. J Clin Oncol 1997; 15: Inoue M, Miyoshi S, Yasumitsu T, et al. Surgical results for SCLC based on the new TNM staging system. Ann Thorac Surg 2000; 70: Komaki R, Meyers CA, Shin DM, et al. Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys 1995; 33: Laurie SA, Logan D, Markman BR, Mackay JA, Evans WK. Practice guideline for the role of combination chemotherapy in the initial management of limited-stage small cell lung cancer. Lung Cancer 2004; 43: Murray N, Coy, Pater JL, et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small cell lung cancer. J Clin Oncol. 1993; 11: Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for smallcell lung cancer. N Eng J Med. 1992; 327: Stahel RA, Ginsberg R, Havemann K, et al. Staging and prognostic factors in small cell lung cancer: a consensus. Lung Cancer 1989; 5: Szczesny TJ, Szczesna A, Shepherd FA, Ginsberg RJ. Surgical treatment of small cell lung cancer. Semin Oncol 2003; 30: Takada M, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small cell lung cancer: results of the Japan Clinical Oncology Group Study J Clin Oncol 2002; 20: Turrisi AT, Kim K, Blum R, et al. Twice daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide.n Eng J Med 1999:340: Van Oosterhout AG, Van de Pol M, Ten Velde GP, Twijnstra A. Neurologic disorders in 203 consecutive patients with small cell lung cancer. Results of a longitudinal study. Cancer 1996; 77: Behandeling Extensive Disease Kleincellig Longcarcinoma (KCLC) - Chua YJ, Steer C, Yip D. et al. Recent advances in management of small cell lung cancer. Cancer Treat Rev 2004; 30: Girling DJ. Comparison of oral etoposide and standard intravenous multi-drug chemotherapy for small-cell lung cancer: a stopped multi-centre randomised trial. Medical Research Council Lung Cancer Working Party. Lancet 1996; 348: Huisman C, Postmus PE, Giaccone G, et al. Second-line chemotherapy and its evaluation in small cell lung cancer. Cancer Treat Rev 1999; 25: Johnson BE, Fischer T, Fischer B, et al. Phase II study of Imatinib in patients with small cell lung cancer. Clin Cancer Res 2003; 9: Hfdst
5 - Noda K, Nishiwaki Y, Kawahara M, et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small cell lung cancer. N Engl J Med 2002; 346: Pujol JL, Carestia L, Daures JP. Is there a case for cisplatin in the treatment of small cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent. Br J Cancer 2000; 83: Sculier JP, Berghmans T, Castaigne C, et al. Maintenance chemotherapy for small cell lung cancer: a critical review of the literature. Lung Cancer 1998; 19: Shepherd FA, Giaccone G, Seymour L, et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small cell lung cancer. J Clin Oncol 2002; 20: Tebbutt NC, Snyder RD, Burns WI. An analysis of the outcomes of treatment of small cell lung cancer in the elderly. Aust NZ J Med 1997; 27: Von Pawel J, Schiller JH, Shepherd FA, et al. Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small cell lung cancer. J Clin Oncol 1999; 17: Yip D, Harper PG. Predictive and prognostic factors in small cell lung cancer: current status. Lung Cancer 2000; 28: Hfdst
Small cell lung cancer (SCLC), which represents 20%
ORIGINAL ARTICLES: GENERAL THORACIC Surgical Results for Small Cell Lung Cancer Based on the New TNM Staging System Masayoshi Inoue, MD, Shinichiro Miyoshi, MD, Tsutomu Yasumitsu, MD, Takashi Mori, MD,
More informationMediastinal Staging. Samer Kanaan, M.D.
Mediastinal Staging Samer Kanaan, M.D. Overview Importance of accurate nodal staging Accuracy of radiographic staging Mediastinoscopy EUS EBUS Staging TNM Definitions T Stage Size of the Primary Tumor
More informationTristate Lung Meeting 2014 Pro-Con Debate: Surgery has no role in the management of certain subsets of N2 disease
Tristate Lung Meeting 2014 Pro-Con Debate: Surgery has no role in the management of certain subsets of N2 disease Jennifer E. Tseng, MD UFHealth Cancer Center-Orlando Health Sep 12, 2014 Background Approximately
More informationPneumonectomy After Induction Rx: Is it Safe?
Pneumonectomy After Induction Rx: Is it Safe? David J. Sugarbaker, M.D. Director, Chief, Division of Thoracic Surgery The Olga Keith Weiss Chair of Surgery of Medicine at, Pneumonectomy after induction
More informationTratamiento Multidisciplinar de Estadios Localmente Avanzados en Cáncer de Pulmón
Tratamiento Multidisciplinar de Estadios Localmente Avanzados en Cáncer de Pulmón Santiago Ponce Aix Servicio Oncología Médica Hospital Universitario 12 de Octubre Madrid Stage III: heterogenous disease
More informationUpdate on Small Cell Lung Cancer
Welcome to Master Class for Oncologists Session 4: 10:00 AM - 10:45 AM San Francisco, CA October 23, 2009 Speaker: Bruce E. Johnson, MD Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical
More informationProtocol of Radiotherapy for Small Cell Lung Cancer
107 年 12 月修訂 Protocol of Radiotherapy for Small Cell Lung Cancer Indication of radiotherapy Limited stage: AJCC (8th edition) stage I-III (T any, N any, M0) that can be safely treated with definitive RT
More informationInduction chemotherapy followed by surgical resection
Surgical Resection for Residual N 2 Disease After Induction Chemotherapy Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Matthew A. Levin, BS, David E. Becker, MA, Roger Keresztes, MD, and Nasser
More informationHeterogeneity of N2 disease
Locally Advanced NSCLC Surgery? No. Ramaswamy Govindan M.D Co-Director, Section of Medical Oncology Alvin J Siteman Cancer Center at Washington University School of Medicine St. Louis, Missouri Heterogeneity
More informationCase presentation. Paul De Leyn, MD, PhD Thoracic Surgery University Hospitals Leuven Belgium
Case presentation Paul De Leyn, MD, PhD Thoracic Surgery University Hospitals Leuven Belgium Perspectives in Lung Cancer Brussels 6-7 march 2009 LEUVEN LUNG CANCER GROUP Department of Thoracic Surgery
More informationMarcel Th. M. van Rens, MD; Aart Brutel de la Rivière, MD, PhD, FCCP; Hans R. J. Elbers, MD, PhD; and Jules M. M. van den Bosch, MD, PhD, FCCP
Prognostic Assessment of 2,361 Patients Who Underwent Pulmonary Resection for Non-small Cell Lung Cancer, Stage I, II, and IIIA* Marcel Th. M. van Rens, MD; Aart Brutel de la Rivière, MD, PhD, FCCP; Hans
More informationPostoperative Mortality in Lung Cancer Patients
Review Postoperative Mortality in Lung Cancer Patients Kanji Nagai, MD, Junji Yoshida, MD, and Mitsuyo Nishimura, MD Surgery for lung cancer frequently results in serious life-threatening complications,
More informationEVIDENCE BASED MANAGEMENT OF STAGE III NSCLC MILIND BALDI
EVIDENCE BASED MANAGEMENT OF STAGE III NSCLC MILIND BALDI Overview Introduction Diagnostic work up Treatment Group 1 Group 2 Group 3 Stage III lung cancer Historically was defined as locoregionally advanced
More informationThe tumor, node, metastasis (TNM) staging system of lung
ORIGINAL ARTICLE Peripheral Direct Adjacent Lobe Invasion Non-small Cell Lung Cancer Has a Similar Survival to That of Parietal Pleural Invasion T3 Disease Hao-Xian Yang, MD, PhD,* Xue Hou, MD, Peng Lin,
More informationEffect of early chemoradiotherapy in patients with limited stage small cell lung cancer
Original Article Radiat Oncol J 2013;31(4):185-190 http://dx.doi.org/10.3857/roj.2013.31.4.185 pissn 2234-1900 eissn 2234-3156 Effect of early chemoradiotherapy in patients with limited stage small cell
More informationAn Update: Lung Cancer
An Update: Lung Cancer Andy Barlow Consultant in Respiratory Medicine Lead Clinician for Lung Cancer (West Herts Hospitals NHS Trust) Lead for EBUS-Harefield Hospital (RB&HFT) Summary Lung cancer epidemiology
More informationMultimodality treatment in limited small cell lung cancer (L-SCLC): different perspectives about the optimal approach
Perspective Multimodality treatment in limited small cell lung cancer (L-SCLC): different perspectives about the optimal approach Valentina Polo 1,2, Giulia Pasello 1 1 Medical Oncology 2, Venetian Oncology
More informationPulmonary function tests 3. Is patient potentially operable? Yes. Inoperable. Yes. Zubrod performance status
te: Consider Clinical Trials as treatment options for eligible patients. INITIAL EVALUATION Pathology consistent with SCLC History and physical Chest x-ray Laboratory studies to include hematological and
More informationSMALL CELL LUNG CANCER Updated Feb 2017 by Dr. Doreen Ezeife (PGY-5 Medical Oncology Resident, University of Calgary)
SMALL CELL LUNG CANCER Updated Feb 2017 by Dr. Doreen Ezeife (PGY-5 Medical Oncology Resident, University of Calgary) Reviewed by Dr. Desiree Hao (Staff Medical Oncologist, University of Calgary) and Dr.
More informationLung Cancer Epidemiology. AJCC Staging 6 th edition
Surgery for stage IIIA NSCLC? Sometimes! Anne S. Tsao, M.D. Associate Professor Director, Mesothelioma Program Director, Thoracic Chemo-Radiation Program May 7, 2011 The University of Texas MD ANDERSON
More informationMEDIASTINAL STAGING surgical pro
MEDIASTINAL STAGING surgical pro Paul E. Van Schil, MD, PhD Department of Thoracic and Vascular Surgery University of Antwerp, Belgium Mediastinal staging Invasive techniques lymph node mapping cervical
More informationTHERAPY OF SMALL-CELL LUNG CANCER Peter Berzinec Specialised Hospital of St Zoerardus Zobor Teaching Base of the Slovak Medical University Nitra,
THERAPY OF SMALL-CELL LUNG CANCER Peter Berzinec Specialised Hospital of St Zoerardus Zobor Teaching Base of the Slovak Medical University Nitra, Slovakia Lancet. 1966;2(7471):979-86. First standard treatment:
More informationSmall Cell Lung Cancer (SCLC)
te: Consider Clinical Trials as treatment options for eligible patients. INITIAL EVALUATION Small Cell Lung Cancer (SCLC) Page 1 of 8 STAGE FURTHER ASSESSMENT Pathology consistent with SCLC History and
More informationInduction Chemoradiation Therapy with Cisplatin plus Irinotecan Followed by Surgical Resection for Superior Sulcus Tumor
Original Article Induction Chemoradiation Therapy with Cisplatin plus Irinotecan Followed by Surgical Resection for Superior Sulcus Tumor Katsuhiko Shimizu, 1 Masao Nakata, 1 Ai Maeda, 1 Takuro Yukawa,
More informationRepeat FDG-PET After Neoadjuvant Therapy is a Predictor of Pathologic Response in Patients With Non-Small Cell Lung Cancer
Repeat FDG-PET After Neoadjuvant Therapy is a Predictor of Pathologic Response in Patients With Non-Small Cell Lung Cancer Robert J. Cerfolio, MD, Ayesha S. Bryant, MSPH, Thomas S. Winokur, MD, Buddhiwardhan
More informationSurgery for early stage NSCLC
1-3 March 2017, Manchester, UK Surgery for early stage NSCLC Dominique H. Grunenwald, MD, PhD Professor Emeritus in Thoracic and Cardiovascular surgery Pierre & Marie Curie University. Paris. France what
More informationUpdate on Limited Small Cell Lung Cancer. Laurie E Gaspar MD, MBA Prof/Chair Radiation Oncology University of Colorado Denver
Update on Limited Small Cell Lung Cancer Laurie E Gaspar MD, MBA Prof/Chair Radiation Oncology University of Colorado Denver Objectives - Limited Radiation Dose Radiation Timing Radiation Volume PCI Neurotoxicity
More informationEarly and locally advanced non-small-cell lung cancer (NSCLC)
Early and locally advanced non-small-cell lung cancer (NSCLC) ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up P. E. Postmus, K. M. Kerr, M. Oudkerk, S. Senan, D. A. Waller, J.
More informationCHAPTER 5 TUMOR SIZE DOES NOT PREDICT PATHOLOGICAL COMPLETE RESPONSE RATES AFTER PRE-OPERATIVE CHEMORADIOTHERAPY FOR NON-SMALL CELL LUNG CANCER
TUMOR SIZE DOES NOT PREDICT PATHOLOGICAL COMPLETE RESPONSE RATES AFTER PRE-OPERATIVE CHEMORADIOTHERAPY FOR NON-SMALL CELL LUNG CANCER Cornelis G. Vos Max R. Dahele Chris Dickhoff Suresh Senan Erik Thunnissen
More informationThe accurate assessment of lymph node involvement is
ORIGINAL ARTICLE Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage Classification? Shenhai Wei, MD, PhD,*
More informationChemotherapy in Lung Cancer
Special Issue Chemotherapy in Lung Cancer Keunchil Park, M.D. Division of Hematology / Oncology, Department of Medicine Sungkyunkwan University School of Medicine, Samsung Medical Center E-mail : kpark@smc.samsung.co.kr
More informationEffect of Chemotherapy in Patients With Resected Small-Cell or Large-Cell Neuroendocrine Carcinoma
ORIGINAL ARTICLE Effect of Chemotherapy in Patients With Resected Small-Cell or Large-Cell Neuroendocrine Carcinoma Nader Abedallaa, MD,* Lise Tremblay, MD, Charlotte Baey,* Dominique Fabre, MD, David
More informationChanges in TNM-classification 7 th edition T T1 2 cm T1a
Introduction 1 Chapter 1 Introduction 9 Currently, cancer is the second leading cause of death in Europe 1. Globally, lung cancer is by far the most common cause of cancer-related deaths, and is by itself
More informationMore than 75,000 procedures in the United States and 3000
General Thoracic Surgery Sedrakyan et al Postoperative chemotherapy for non small cell lung cancer: A systematic review and meta-analysis Artyom Sedrakyan, MD, PhD a,b Jan van Der Meulen, PhD a,b Ken O
More informationAccepted Manuscript. Adjuvant Chemotherapy in Stage I Lung Cancer: Is More Better? Chuong D. Hoang, MD
Accepted Manuscript Adjuvant Chemotherapy in Stage I Lung Cancer: Is More Better? Chuong D. Hoang, MD PII: S0022-5223(18)31821-X DOI: 10.1016/j.jtcvs.2018.06.069 Reference: YMTC 13198 To appear in: The
More informationSurgical intervention for small-cell lung cancer: what is the surgical role?
Gen Thorac Cardiovasc Surg (2012) 60:401 405 DOI 10.1007/s11748-012-0072-9 CURRENT TOPICS REVIEW ARTICLE Surgical intervention for small-cell lung cancer: what is the surgical role? Masayoshi Inoue Noriyoshi
More informationAccording to the current International Union
Treatment of Stage II Non-small Cell Lung Cancer* Walter J. Scott, MD, FCCP; John Howington, MD, FCCP; and Benjamin Movsas, MD Based on clinical assessment alone, patients with stage II non-small cell
More informationIntroduction: Methods: Results: Conclusions: PATIENTS AND METHODS Key Words: 1770
Original Article Utilization of Hyperfractionated Radiation in Small-Cell Lung Cancer and Its Impact on Survival David Schreiber, MD,* Andrew T. Wong, MD,* David Schwartz, MD,* and Justin Rineer, MD Introduction:
More informationClinical Management Guideline for Small Cell Lung Cancer
Diagnosis and Staging: Key Points 1. Ensure a CT scan that is
More informationTHORACIC MALIGNANCIES
THORACIC MALIGNANCIES Summary for Malignant Malignancies. Lung Ca 1 Lung Cancer Non-Small Cell Lung Cancer Diagnostic Evaluation for Non-Small Lung Cancer 1. History and Physical examination. 2. CBCDE,
More informationThe right middle lobe is the smallest lobe in the lung, and
ORIGINAL ARTICLE The Impact of Superior Mediastinal Lymph Node Metastases on Prognosis in Non-small Cell Lung Cancer Located in the Right Middle Lobe Yukinori Sakao, MD, PhD,* Sakae Okumura, MD,* Mun Mingyon,
More informationProton therapy for post-operative radiation therapy of non-small cell lung cancer
Mini-Review Proton therapy for post-operative radiation therapy of non-small cell lung cancer Annemarie Fernandes Shepherd Memorial Sloan Kettering Cancer Center, Basking Ridge, NJ, USA Correspondence
More informationCALGB Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer
CALGB 30610 Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer Jeffrey A. Bogart Department of Radiation Oncology Upstate Medical University Syracuse, NY Small Cell Lung Cancer Estimated 33,000
More informationPatients with pathologically diagnosed involved mediastinal
MINI-SYMPOSIUM ON EMERGING TECHNIQUES FOR LUNG CANCER STAGING European Trends in Preoperative and Intraoperative Nodal Staging: ESTS Guidelines P. De Leyn, MF, PhD,* D. Lardinois, MD, P. Van Schil, MD,
More informationPET/CT in lung cancer
PET/CT in lung cancer Andrei Šamarin North Estonia Medical Centre 3 rd Baltic Congress of Radiology 08.10.2010 Imaging in lung cancer Why do we need PET/CT? CT is routine imaging modality for staging of
More informationIs neoadjuvant chemotherapy mandatory for limited-disease small-cell lung cancer?
Interactive CardioVascular and Thoracic Surgery Advance Access published August 24, 2014 Interactive CardioVascular and Thoracic Surgery (2014) 1 7 doi:10.1093/icvts/ivu262 THORACIC Is neoadjuvant chemotherapy
More information1 Oregon Health & Science University, Portland, OR 2 Stritch School of Medicine, Loyola University Chicago, Chicago, IL
Current treatment practices for limited-stage small cell lung cancer: A survey of US radiation oncologists on the timing of thoracic radiotherapy with chemotherapy Matthew J. Farrell 1, Jehan Yahya 1,
More informationEffect of radiotherapy on the treatment of patients with extensive stage small cell lung cancer
Effect of radiotherapy on the treatment of patients with extensive stage small cell lung cancer C. Wu, T. Wang, J. Wang, B. Qu, H. Wang and Y. Hu Department of Oncology, The General Hospital of the People
More informationNon-small Cell Lung Cancer: Multidisciplinary Role: Role of Medical Oncologist
Non-small Cell Lung Cancer: Multidisciplinary Role: Role of Medical Oncologist Vichien Srimuninnimit, MD. Medical Oncology Division Faculty of Medicine, Siriraj Hospital Outline Resectable NSCLC stage
More informationTumors of the superior sulcus and central T4 tumors are an
ORIGINAL ARTICLE Survival after Trimodality Treatment for Superior Sulcus and Central T4 Non-small Cell Lung Cancer Paul De Leyn, MD, PhD,* Johan Vansteenkiste, MD, PhD, Yolande Lievens, MD, PhD, Dirk
More informationCANCER TREATMENT REGIMENS
CANCER TREATMENT S Lung Cancer The selection, dosing, and administration of anticancer agents and the management of associated toxicities are complex. Drug dose modifications and schedule and initiation
More informationThe Significance of One-Station N2 Disease in the Prognosis of Patients With Nonsmall-Cell Lung Cancer
ORIGINAL ARTICLES: SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related to this article, you must have either an STS
More informationLung cancer Surgery. 17 TH ESO-ESMO MASTERCLASS IN CLINICAL ONCOLOGY March, 2017 Berlin, Germany
17 TH ESO-ESMO MASTERCLASS IN CLINICAL ONCOLOGY 24-29 March, 2017 Berlin, Germany Lung cancer Surgery Sven Hillinger MD, Thoracic Surgery, University Hospital Zurich Case 1 59 y, female, 40 py, incidental
More informationThe start of chemotherapy until the end of radiotherapy in patients with limited-stage small cell lung cancer
ORIGINAL ARTICLE Korean J Intern Med 2013;28:449-455 The start of chemotherapy until the end of radiotherapy in patients with limited-stage small cell lung cancer Kyoung Ju Lee 1, Eun Joo Lee 2, Gyu Young
More informationSurgery for Early-Stage Small Cell Lung Cancer
1132 Surgery for Early-Stage Small Cell Lung Cancer Bryan J. Schneider, MD a ; Ashish Saxena, MD a ; and Robert J. Downey, MD b ; New York, New York Key Words Small cell lung cancer, surgery, resection,
More informationThe Itracacies of Staging Patients with Suspected Lung Cancer
The Itracacies of Staging Patients with Suspected Lung Cancer Gerard A. Silvestri, MD,MS, FCCP Professor of Medicine Medical University of South Carolina Charleston, SC silvestri@musc.edu Staging Lung
More informationA Prospective Study of Indications for Mediastinoscopy in Lung Cancer With CT Findings, Tumor Size, and Tumor Markers
GENERAL THORACIC A Prospective Study of Indications for Mediastinoscopy in Lung Cancer With CT Findings, Tumor Size, and Tumor Markers Hideki Kimura, MD, PhD, Naomichi Iwai, MD, PhD, Soichiro Ando, MD,
More informationProphylactic cranial irradiation or no prophylactic cranial irradiation in metastatic small cell lung cancer: is it a relevant question once again?
Editorial Prophylactic cranial irradiation or no prophylactic cranial irradiation in metastatic small cell lung cancer: is it a relevant question once again? Cecile Le Pechoux 1, Angela Botticella 1, Antonin
More information肺癌放射治療新進展 Recent Advance in Radiation Oncology in Lung Cancer 許峰銘成佳憲國立台灣大學醫學院附設醫院腫瘤醫學部
肺癌放射治療新進展 Recent Advance in Radiation Oncology in Lung Cancer 許峰銘成佳憲國立台灣大學醫學院附設醫院腫瘤醫學部 Outline Current status of radiation oncology in lung cancer Focused on stage III non-small cell lung cancer Radiation
More informationThe Role of Consolidation Therapy for Stage III Non-Small Cell Lung Cancer With Persistent N2 Disease After Induction Chemotherapy
The Role of Consolidation Therapy for Stage III Non-Small Cell Lung Cancer With Persistent N2 Disease After Induction Chemotherapy Arya Amini, BA, Arlene M. Correa, PhD, Ritsuko Komaki, MD, Joe Y. Chang,
More informationThis document is the result of a comprehensive
Small Cell Lung Cancer* George R. Simon, MD, FCCP; and Henry Wagner, MD Among patients with lung cancers, the proportion of those with small cell lung cancer (SCLC) has decreased over the last decade.
More informationPERIOPERATIVE TREATMENT OF NON SMALL CELL LUNG CANCER. Virginie Westeel Chest Disease Department University Hospital Besançon, France
PERIOPERATIVE TREATMENT OF NON SMALL CELL LUNG CANCER Virginie Westeel Chest Disease Department University Hospital Besançon, France LEARNING OBJECTIVES 1. To understand the potential of perioperative
More informationUniversity of Pennsylvania School of Medicine and Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania
The Oncologist Lung Cancer Which Patients with Stage III Non-Small Cell Lung Cancer Should Undergo Surgical Resection? VIVEK PATEL, JOSEPH B. SHRAGER University of Pennsylvania School of Medicine and Philadelphia
More informationBrain Metastases in Locally Advanced Nonsmall Cell Lung Carcinoma after Multimodality Treatment
605 Brain Metastases in Locally Advanced Nonsmall Cell Lung Carcinoma after Multimodality Treatment Risk Factors Analysis Giovanni Luca Ceresoli, M.D. 1 Michele Reni, M.D. 1 Giuseppe Chiesa, M.D. 2 Angelo
More informationRadiation Therapy for the Oncologist in Breast Cancer
REVIEW ARTICLE Chonnam National University Medical School Sung-Ja Ahn, M.D. Adjuvant Tamoxifen with or without in Patients 70 Years of Age with Stage I ER-Positive Breast Cancer: Efficacy Outcomes (10
More informationSCLC: Developments in systemic treatment
SCLC: Developments in systemic treatment Egbert F. Smit, Dept. Pulmonary Diseases, Vrije Universiteit Medisch Centrum, Amsterdam, The Netherlands Staging Outline First line treatment Second line treatment
More informationEndobronchial Ultrasound in the Diagnosis & Staging of Lung Cancer
Endobronchial Ultrasound in the Diagnosis & Staging of Lung Cancer Dr Richard Booton PhD FRCP Lead Lung Cancer Clinician, Consultant Respiratory Physician & Speciality Director Manchester University NHS
More informationMolly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010
LSU HEALTH SCIENCES CENTER NSCLC Guidelines Feist-Weiller Cancer Center Molly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010 Initial Evaluation/Intervention: 1. Pathology Review 2. History and Physical
More informationSurgical Treatment of Lung Cancer with Vertebral Invasion
Original Article Surgical Treatment of Lung Cancer with Vertebral Invasion Kiyoshi Koizumi, MD, Shuji Haraguchi, MD, Tomomi Hirata, MD, Kyoji Hirai, MD, Iwao Mikami, MD, Shigeki Yamagishi, MD, Daisuke
More informationsurgical approach for resectable NSCLC
surgical approach for resectable NSCLC Dominique H. Grunenwald, MD, PhD Professor Emeritus in Thoracic and Cardiovascular surgery Pierre & Marie Curie University. Paris. France 1933 Graham EA, Singer JJ.
More informationIs surgery indicated in patients with stage IIIa lung cancer and mediastinal nodal involvement?
doi:10.1510/icvts.2011.267872 Interactive CardioVascular and Thoracic Surgery 13 (2011) 303-310 www.icvts.org Best evidence topic - Thoracic oncologic Is surgery indicated in patients with stage IIIa lung
More informationWorkshop LA RADIOTERAPIA DEI TUMORI RARI I TIMOMI : INDICAZIONI
XXI CONGRESSO NAZIONALE AIRO Genova, 19-22 novembre 2011 Workshop LA RADIOTERAPIA DEI TUMORI RARI I TIMOMI : INDICAZIONI PIERA NAVARRIA Unità Operativa di Radioterapia e Radiochirurgia Humanitas Cancer
More informationSlide 1. Slide 2. Slide 3. Investigation and management of lung cancer Robert Rintoul. Epidemiology. Risk factors/aetiology
Slide 1 Investigation and management of lung cancer Robert Rintoul Department of Thoracic Oncology Papworth Hospital Slide 2 Epidemiology Second most common cancer in the UK (after breast). 38 000 new
More informationLA RADIOTERAPIA NEL TRATTAMENTO INTEGRATO DEL CANCRO DEL POLMONE NON MICROCITOMA NSCLC I-II
AUSL BA/4 Ospedale S. Paolo Bari U.O. Complessa di Chirurgia Toracica LA RADIOTERAPIA NEL TRATTAMENTO INTEGRATO DEL CANCRO DEL POLMONE NON MICROCITOMA NSCLC I-II stadio L opinione del chirurgo Francesco
More informationOriginal Study. 40 Clinical Lung Cancer January 2013
Original Study Prophylactic Cranial Irradiation for Patients With Limited-Stage Small-Cell Lung Cancer With Response to Chemoradiation Patricia Tai, 1 Avi Assouline, 2 Kurian Joseph, 3 Larry Stitt, 4 Edward
More informationThe role of adjuvant chemotherapy following resection of early stage thymoma
Perspective The role of adjuvant chemotherapy following resection of early stage thymoma Masatsugu Hamaji Department of Thoracic Surgery, Kyoto University Hospital, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto,
More informationSmall-cell lung cancer (SCLC) is an aggressive neuroendocrine
ORIGINAL ARTICLE Tolerability of Accelerated Chest Irradiation and Impact on Survival of Prophylactic Cranial Irradiation in Patients with Limited-stage Small Cell Lung Cancer: Review of a Single Institution
More informationAdjuvant Radiotherapy for completely resected NSCLC
Adjuvant Radiotherapy for completely resected NSCLC ESMO Preceptorship on lung Cancer Manchester February 2017 Cécile Le Péchoux Radiation Oncology Department IOT Institut d Oncologie Thoracique Local
More informationTHE EFFECT OF USING PET-CT FUSION ON TARGET VOLUME DELINEATION AND DOSE TO ORGANS AT RISK IN 3D RADIOTHERAPY PLANNING OF PATIENTS WITH NSSLC
THE EFFECT OF USING PET-CT FUSION ON TARGET VOLUME DELINEATION AND DOSE TO ORGANS AT RISK IN 3D RADIOTHERAPY PLANNING OF PATIENTS WITH NSSLC Hana Al-Mahasneh,M.D*., Mohammad Khalaf Al-Fraessan, M.R.N,
More informationManagement of Small Cell Lung Cancer* ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Supplement DIAGNOSIS AND MANAGEMENT OF LUNG CANCER: ACCP GUIDELINES Management of Small Cell Lung Cancer* ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) George R. Simon, MD, FCCP; and Andrew
More informationLUNG CANCER. Agnieszka Słowik, MD. Department of Oncology, University Hospital in Cracow Jagiellonian University
LUNG CANCER Agnieszka Słowik, MD Department of Oncology, University Hospital in Cracow Jagiellonian University Epidemiology Most common malignancy worldwide Place of lung cancer among other malignancies
More informationsystematic mediastinal lymph node
62 Original Article Singapore Med 1 27, 48 (7) : Cardiac, Thoracic and Vascular Surgery, National University Hospital, 5 Lower Kent Ridge Road, Singapore 11974 Chong CF, BSc, MD, FRCSE Registrar Lee CN,
More informationDisclosures. Preoperative Treatment: Chemotherapy or ChemoRT? Adjuvant chemotherapy helps. so what about chemo first?
Disclosures Preoperative Treatment: Chemotherapy or ChemoRT? Advisory boards Genentech (travel only), Pfizer Salary support for clinical trials Celgene, Merck, Merrimack Matthew Gubens, MD, MS Assistant
More informationVideo-Mediastinoscopy Thoracoscopy (VATS)
Surgical techniques Video-Mediastinoscopy Thoracoscopy (VATS) Gunda Leschber Department of Thoracic Surgery ELK Berlin Chest Hospital, Berlin, Germany Teaching Hospital of Charité Universitätsmedizin Berlin
More informationStandard care plan for Prophylactic Cranial Irradiation for Limited Stage (stage I-III) Small Cell Lung Cancer (25Gy in 10 fractions) References
CHEMOTHERAPY CARE PLAN Document Title: Document Type: Subject: Approved by: Prophylactic Cranial Irradiation for Limited-stage Small Cell Lung Cancer (20Gy in 5 fractions) Clinical Guideline Standard Care
More informationNorth of Scotland Cancer Network Clinical Management Guideline for Non Small Cell Lung Cancer
THIS DOCUMENT IS North of Scotland Cancer Network Clinical Management Guideline for Non Small Cell Lung Cancer [Based on WOSCAN NSCLC CMG with further extensive consultation within NOSCAN] UNCONTROLLED
More informationStato dell arte del. Antonio ROSSI, MD. Division of Medical Oncology, S.G. MOSCATI HOSPITAL, AVELLINO - ITALY
Stato dell arte del trattamento del microcitoma Antonio ROSSI, MD Division of Medical Oncology, S.G. MOSCATI HOSPITAL, AVELLINO - ITALY Truly has become small. Last session/day in all meetings One chemo
More informationPost-Induction PET Does Not Correlate with Persistent Nodal Disease or Overall Survival in Surgically Treated Stage IIIA Non-Small Cell Lung Cancer
Post-Induction PET Does Not Correlate with Persistent Nodal Disease or Overall Survival in Surgically Treated Stage IIIA Non-Small Cell Lung Cancer R. Taylor Ripley, Kei Suzuki, Kay See Tan, Manjit Bains,
More informationRisk Factors for Occult Mediastinal Metastases in Clinical Stage I Non-Small Cell Lung Cancer
ORIGINAL ARTICLES: SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related to this article, you must have either an STS
More informationControversy continues to surround the role of surgery for patients
General Thoracic Surgery Keller et al Prolonged survival in patients with resected non small cell lung cancer and single-level N2 disease Steven M. Keller, MD, a Mark G. Vangel, PhD, b Henry Wagner, MD,
More informationPerioperative outcomes and lymph node assessment after induction therapy in patients with clinical N1 or N2 non-small cell lung cancer
Original Article Perioperative outcomes and lymph node assessment after induction therapy in patients with clinical N1 or N2 non-small cell lung cancer Jessica Glover 1, Frank O. Velez-Cubian 2, Kavian
More informationSurgery for non-small cell lung cancer with unsuspected metastasis to ipsilateral mediastinal or subcarinal nodes (N2 disease)
Eur J Cardio-thorac Surg (1996) 10:649-655 Springer-Verlag 1996 P. De Leyn P. Schoonooghe G. Deneffe D. Van Raemdonck W. Coosemans J. Vansteenkiste T. Lerut Surgery for non-small cell lung cancer with
More informationTreatment of Small Cell Lung Cancer
CHEST Supplement DIAGNOSIS AND MANAGEMENT OF LUNG CANCER, 3RD ED: ACCP GUIDELINES Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice
More informationPrognostic value of visceral pleura invasion in non-small cell lung cancer q
European Journal of Cardio-thoracic Surgery 23 (2003) 865 869 www.elsevier.com/locate/ejcts Prognostic value of visceral pleura invasion in non-small cell lung cancer q Jeong-Han Kang, Kil Dong Kim, Kyung
More informationThe Role of Radiotherapy in the Treatment of Small-Cell Lung Cancer
Curr. Treat. Options in Oncol. (2015) 16: 56 DOI 10.1007/s11864-015-0372-2 Lung Cancer (HA Wakelee, Section Editor) The Role of Radiotherapy in the Treatment of Small-Cell Lung Cancer Kaname Nosaki, M.D.
More informationShort-Course Induction Chemoradiotherapy With Paclitaxel for Stage III Non-Small-Cell Lung Cancer
Short-Course Induction Chemoradiotherapy With Paclitaxel for Stage III Non-Small-Cell Lung Cancer Thomas W. Rice, MD, David J. Adelstein, MD, Jay P. Ciezki, MD, Mark E. Becker, MD, Lisa A. Rybicki, MS,
More informationRESEARCH ARTICLE. Evrim Bayman 1 *, Durmus Etiz 1, Melek Akcay 1, Guntulu Ak 2. Abstract. Introduction
DOI:http://dx.doi.org/10.7314/APJCP.2014.15.15.6263 RESEARCH ARTICLE Timing of Thoracic Radiotherapy in Limited Stage Small Cell Lung Cancer: Results of Early Versus Late Irradiation from a Single Institution
More informationRadiation Therapy in SCLC. What is New? Prof. Dr. Hoda Abdel Baky El Bakry Cairo Cancer Institute Radiation Oncology Department
Radiation Therapy in SCLC What is New? Prof. Dr. Hoda Abdel Baky El Bakry Cairo Cancer Institute Radiation Oncology Department Background Overview Small Cell Lung cancer constitute about 15 % of all newly
More informationFDG-PET/CT imaging for mediastinal staging in patients with potentially resectable non-small cell lung cancer.
FDG-PET/CT imaging for mediastinal staging in patients with potentially resectable non-small cell lung cancer. Schmidt-Hansen, M; Baldwin, DR; Zamora, J 2018 American Medical Association. All Rights Reserved.
More informationFifteen-year follow-up of all patients in a study of
Br. J. Cancer (1985), 52, 867-873 Fifteen-year follow-up of all patients in a study of post-operative chemotherapy for bronchial carcinoma D.J. Girling, H. Stott, R.J. Stephens & W. Fox Medical Research
More information